<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="Review Phages and Their Role in Gastrointestinal Disease: Focus on" exact="Inflammatory" post="Bowel Disease https://orcid.org/0000-0002-1201-5184MaronekMartin1LinkRene2AmbroLubos2https://orcid.org/0000-0001-8211-907XGardlikRoman1*[1], martin.maronek@gmail.com[2], rlink4@gmail.comlubos.ambro@upjs.sk *Correspondence: romangardlik@gmail.com; Tel.: +4212-9011-92-96"/>
 <result pre="and Their Role in Gastrointestinal Disease: Focus on Inflammatory Bowel" exact="Disease" post="https://orcid.org/0000-0002-1201-5184MaronekMartin1LinkRene2AmbroLubos2https://orcid.org/0000-0001-8211-907XGardlikRoman1*[1], martin.maronek@gmail.com[2], rlink4@gmail.comlubos.ambro@upjs.sk *Correspondence: romangardlik@gmail.com; Tel.: +4212-9011-92-96 epub: 2020-4-4collection:"/>
 <result pre="of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Abstract" exact="Inflammatory" post="bowel diseases (IBDs) are a group of chronic autoinflammatory"/>
 <result pre="the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Abstract Inflammatory" exact="bowel" post="diseases (IBDs) are a group of chronic autoinflammatory diseases"/>
 <result pre="(http://creativecommons.org/licenses/by/4.0/). Abstract Inflammatory bowel diseases (IBDs) are a group of" exact="chronic" post="autoinflammatory diseases including Crohn’s disease and ulcerative colitis. Although"/>
 <result pre="(IBDs) are a group of chronic autoinflammatory diseases including Crohn’s" exact="disease" post="and ulcerative colitis. Although the molecular mechanisms governing the"/>
 <result pre="a group of chronic autoinflammatory diseases including Crohn’s disease and" exact="ulcerative colitis." post="Although the molecular mechanisms governing the pathogenesis of gastrointestinal"/>
 <result pre="concept of phage therapy and its future applications. virome phageome" exact="inflammatory bowel disease" post="intestinal inflammation phage therapy 1. Introduction The human body"/>
 <result pre="of phage therapy and its future applications. virome phageome inflammatory" exact="bowel" post="disease intestinal inflammation phage therapy 1. Introduction The human"/>
 <result pre="phage therapy and its future applications. virome phageome inflammatory bowel" exact="disease" post="intestinal inflammation phage therapy 1. Introduction The human body"/>
 <result pre="microbiome. It is commonly present on the skin, urogenital, and" exact="respiratory" post="tracts; however, the most abundant microbial populations can be"/>
 <result pre="the most abundant microbial populations can be found in the" exact="lower" post="part of the gastrointestinal tract, the colon. The part"/>
 <result pre="intestinal microbiome was clearly primarily studied from the view of" exact="gastrointestinal disease." post="Inflammatory bowel diseases (IBDs) are a group of chronic"/>
 <result pre="was clearly primarily studied from the view of gastrointestinal disease." exact="Inflammatory" post="bowel diseases (IBDs) are a group of chronic autoinflammatory"/>
 <result pre="clearly primarily studied from the view of gastrointestinal disease. Inflammatory" exact="bowel" post="diseases (IBDs) are a group of chronic autoinflammatory diseases"/>
 <result pre="gastrointestinal disease. Inflammatory bowel diseases (IBDs) are a group of" exact="chronic" post="autoinflammatory diseases including ulcerative colitis (UC) and Crohn’s disease"/>
 <result pre="diseases (IBDs) are a group of chronic autoinflammatory diseases including" exact="ulcerative colitis" post="(UC) and Crohn’s disease (CD). They are characterized by"/>
 <result pre="(IBDs) are a group of chronic autoinflammatory diseases including ulcerative" exact="colitis" post="(UC) and Crohn’s disease (CD). They are characterized by"/>
 <result pre="of chronic autoinflammatory diseases including ulcerative colitis (UC) and Crohn’s" exact="disease" post="(CD). They are characterized by a long-lasting recurrent inflammation"/>
 <result pre="and Crohn’s disease (CD). They are characterized by a long-lasting" exact="recurrent" post="inflammation of various parts of the gastrointestinal tract. Epidemiological"/>
 <result pre="a large variety of available therapies, none of them offer" exact="complete" post="remission to every patient. Moreover, frequent cases of treatment"/>
 <result pre="effects. With this in mind, finding new approaches to treat" exact="chronic" post="inflammation in IBD is imperative. As such, fecal microbiota"/>
 <result pre="therapy (PT) are being considered. 2. Role of Dysbiosis in" exact="Disease" post="It is estimated that an average human colon contains"/>
 <result pre="is estimated that an average human colon contains approximately 1011" exact="bacterial" post="cells per one gram of fecal content [5,6,7]. More"/>
 <result pre="Sender et al. They proposed a ratio of only 1.3:1" exact="bacterial" post="to human cells on the basis of certain assumptions"/>
 <result pre="are, in general, much smaller than prokaryotes, estimates for their" exact="total" post="abundance in the human gut may vary even more"/>
 <result pre="it is associated with many even seemingly unrelated diseases including" exact="liver disease" post="[11], neurobehavioral dysfunction in non-alcoholic steatosis [12], lung cancer"/>
 <result pre="is associated with many even seemingly unrelated diseases including liver" exact="disease" post="[11], neurobehavioral dysfunction in non-alcoholic steatosis [12], lung cancer"/>
 <result pre="including liver disease [11], neurobehavioral dysfunction in non-alcoholic steatosis [12]," exact="lung cancer" post="[13], or obstructive sleep apnea [14]. Furthermore, dysbiosis may"/>
 <result pre="liver disease [11], neurobehavioral dysfunction in non-alcoholic steatosis [12], lung" exact="cancer" post="[13], or obstructive sleep apnea [14]. Furthermore, dysbiosis may"/>
 <result pre="neurobehavioral dysfunction in non-alcoholic steatosis [12], lung cancer [13], or" exact="obstructive sleep apnea" post="[14]. Furthermore, dysbiosis may provoke the development or exacerbate"/>
 <result pre="dysfunction in non-alcoholic steatosis [12], lung cancer [13], or obstructive" exact="sleep apnea" post="[14]. Furthermore, dysbiosis may provoke the development or exacerbate"/>
 <result pre="development or exacerbate the course of inflammatory diseases such as" exact="rheumatoid arthritis" post="[15], systemic lupus erythematosus [16], or IBD [17]. The"/>
 <result pre="or exacerbate the course of inflammatory diseases such as rheumatoid" exact="arthritis" post="[15], systemic lupus erythematosus [16], or IBD [17]. The"/>
 <result pre="the course of inflammatory diseases such as rheumatoid arthritis [15]," exact="systemic" post="lupus erythematosus [16], or IBD [17]. The term &quot;dysbiosis�?"/>
 <result pre="course of inflammatory diseases such as rheumatoid arthritis [15], systemic" exact="lupus erythematosus" post="[16], or IBD [17]. The term &quot;dysbiosis�? usually encompasses"/>
 <result pre="bacteria are not the only residents of the human gut," exact="bacterial" post="dysbiosis very likely also affects viral composition and abundance."/>
 <result pre="of the human gut, bacterial dysbiosis very likely also affects" exact="viral" post="composition and abundance. Bacterial and viral dysbiosis may possibly"/>
 <result pre="very likely also affects viral composition and abundance. Bacterial and" exact="viral" post="dysbiosis may possibly play a role in the development"/>
 <result pre="for short), are being associated with metabolic disorders such as" exact="type 1" post="diabetes [18], type 2 diabetes [19], or neurodegenerative diseases"/>
 <result pre="are being associated with metabolic disorders such as type 1" exact="diabetes" post="[18], type 2 diabetes [19], or neurodegenerative diseases such"/>
 <result pre="associated with metabolic disorders such as type 1 diabetes [18]," exact="type 2" post="diabetes [19], or neurodegenerative diseases such as Parkinson’s disease"/>
 <result pre="metabolic disorders such as type 1 diabetes [18], type 2" exact="diabetes" post="[19], or neurodegenerative diseases such as Parkinson’s disease [20]."/>
 <result pre="type 2 diabetes [19], or neurodegenerative diseases such as Parkinson’s" exact="disease" post="[20]. 3. Composition of Virome in Health and Disease"/>
 <result pre="Parkinson’s disease [20]. 3. Composition of Virome in Health and" exact="Disease" post="The analysis of the composition of each component of"/>
 <result pre="al. They analyzed the composition of the fecal virome in" exact="adult" post="female monozygotic twins and their mothers throughout a period"/>
 <result pre="They analyzed the composition of the fecal virome in adult" exact="female" post="monozygotic twins and their mothers throughout a period of"/>
 <result pre="differences remained low [22]. Subsequently, Pérez-Brocal et al. described the" exact="viral" post="and microbial composition in fecal samples from CD patients"/>
 <result pre="microbial composition in fecal samples from CD patients and controls." exact="Viral" post="families Siphoviridae, Myoviridae, and Podoviridae, among others belonging to"/>
 <result pre="[23]. This research group later continued with the assessment of" exact="bacterial" post="and viral populations in samples from CD patients in"/>
 <result pre="research group later continued with the assessment of bacterial and" exact="viral" post="populations in samples from CD patients in various stages"/>
 <result pre="in samples from CD patients in various stages of the" exact="disease" post="in comparison with control individuals. Interestingly, the impact of"/>
 <result pre="of individual variability and sample origin on the composition of" exact="viral" post="communities was larger than the presence of CD. On"/>
 <result pre="basis of these findings, the authors concluded that bacteria reflect" exact="disease" post="status in a more accurate manner than viruses [24]."/>
 <result pre="be expected, mucosal samples from CD patients had a higher" exact="viral" post="count compared with healthy individuals. By contrast, ulcerated mucosa"/>
 <result pre="higher viral count compared with healthy individuals. By contrast, ulcerated" exact="mucosa" post="showed a lower amount of phages than the healthy"/>
 <result pre="compared with healthy individuals. By contrast, ulcerated mucosa showed a" exact="lower" post="amount of phages than the healthy non-ulcerated intestinal tissue"/>
 <result pre="some suggested that no differences exist between ulcerated and non-ulcerated" exact="mucosa" post="[26] while others showed less bacteria in ulcerated mucosa"/>
 <result pre="non-ulcerated mucosa [26] while others showed less bacteria in ulcerated" exact="mucosa" post="[27]. Therefore, whether healthy or ulcerated mucosa is inhabited"/>
 <result pre="bacteria in ulcerated mucosa [27]. Therefore, whether healthy or ulcerated" exact="mucosa" post="is inhabited by more bacteria and the exact role"/>
 <result pre="phages in their abundance are unclear. Wagner et al. amplified" exact="viral" post="sequences from ileal and colonic biopsies from pediatric CD"/>
 <result pre="colonic biopsies from pediatric CD patients and found the most" exact="viral" post="hits in CD ileal samples followed by control ileal"/>
 <result pre="by control ileal and CD colonic samples. The majority of" exact="viral" post="reads belonged to Caudovirales [28]. A study by Norman"/>
 <result pre="these results were supported by a T-cell transfer model of" exact="colitis" post="in mice. In animals treated with T cells, reads"/>
 <result pre="genome of Caudovirales accounted for less than 0.01% of the" exact="total" post="viral reads [30]. Consistent with these findings, Caudovirales phages"/>
 <result pre="of Caudovirales accounted for less than 0.01% of the total" exact="viral" post="reads [30]. Consistent with these findings, Caudovirales phages were"/>
 <result pre="between CD and controls [31]. The analysis of the rectal" exact="mucosa" post="of UC patients revealed an expansion of Caudovirales. However,"/>
 <result pre="UC cohort compared with controls, they did not find any" exact="viral" post="taxa that could be implicated in the onset of"/>
 <result pre="seem to be important in the pathogenesis of Clostridium difficile" exact="infection" post="(CDI). In patients suffering from CDI, higher abundance but"/>
 <result pre="infection (CDI). In patients suffering from CDI, higher abundance but" exact="lower" post="diversity of this order was detected in comparison with"/>
 <result pre="of Caudovirales in CDI patients [34]. In the case of" exact="colorectal carcinoma" post="(CRC), results are inconclusive. A study by Hannigan et"/>
 <result pre="Caudovirales in CDI patients [34]. In the case of colorectal" exact="carcinoma" post="(CRC), results are inconclusive. A study by Hannigan et"/>
 <result pre="al. did not find significant differences in Shannon diversity or" exact="viral" post="richness between patients and healthy controls. Their findings suggested"/>
 <result pre="suggested an indirect role for the virome by altering the" exact="bacterial" post="community [35]. Conversely, viral dysbiosis is associated with early-"/>
 <result pre="for the virome by altering the bacterial community [35]. Conversely," exact="viral" post="dysbiosis is associated with early- and late-stage CRCs. It"/>
 <result pre="CRCs. It was reported that these associations were independent of" exact="tumor" post="stage, lymph node metastases, or other clinical markers [36]."/>
 <result pre="began to uncover differences in the amount and abundance of" exact="viral" post="sequences in stool samples from IBD patients. In one"/>
 <result pre="showed increased abundance of Hepeviridae compared with controls. The gut" exact="mucosa" post="of UC samples was characterized by the lower concentration"/>
 <result pre="The gut mucosa of UC samples was characterized by the" exact="lower" post="concentration of Polydnaviridae and Tymoviridae, while the CD gut"/>
 <result pre="lower concentration of Polydnaviridae and Tymoviridae, while the CD gut" exact="mucosa" post="had reduced abundance of Virgaviridae [38]. Several caveats should"/>
 <result pre="The ratios reported by other studies vary considerably, but many" exact="viral" post="sequences must apparently be characterized in order to obtain"/>
 <result pre="sequences must apparently be characterized in order to obtain a" exact="complete" post="picture. However, higher abundance of a certain taxon does"/>
 <result pre="unraveled. Accordingly, our current understanding of virome in health and" exact="disease" post="may be biased. Therefore, additional experiments will have to"/>
 <result pre="mutations in each new generation, a few bacteria escape their" exact="viral" post="attackers on every occasion. However, this process works vice"/>
 <result pre="vice versa as well; in each new generation, a few" exact="viral" post="particles are slightly different from the rest, which means"/>
 <result pre="division, each daughter cell will carry, in its genome, the" exact="viral" post="sequence as well. This process is called lysogeny and"/>
 <result pre="In this case, usually, only a few copies of the" exact="viral" post="genetic information are being synthesized at any given time."/>
 <result pre="of their success in reproduction via the fitness of their" exact="bacterial" post="host. Some hypotheses provided explanations on the basis of"/>
 <result pre="The results are in line with another study where a" exact="stable" post="core virome in healthy individuals was observed [41]. Thus,"/>
 <result pre="mucus layer of the intestine based on the amount of" exact="bacterial" post="load in various parts of the mucosal layer [42,43]."/>
 <result pre="phageome and subsequently bacteriome of a person suffering from a" exact="disease" post="which is thought to stem from bacterial origin. Usually,"/>
 <result pre="suffering from a disease which is thought to stem from" exact="bacterial" post="origin. Usually, it involves several steps: modification of the"/>
 <result pre="in a way which ensures successful adsorption to the desired" exact="bacterial" post="strain; preparation of either one or more phage strains;"/>
 <result pre="d’Hérelle cured patients suffering from diseases, such as dysentery or" exact="cholera" post="[44]. However, the discovery and usage of antibiotics decades"/>
 <result pre="microbiome modification via, more or less, the selective destruction of" exact="bacterial" post="cells. Furthermore, however, there are two possible ways via"/>
 <result pre="species (ROS). In addition, this phage inhibited ROS generation from" exact="peripheral" post="blood polymorphonuclear leukocytes stimulated with either lipopolysaccharides or strains"/>
 <result pre="be modulated by Staphylococcus aureus phage [52]. In fact, the" exact="systemic" post="presence of phages in the human body could play"/>
 <result pre="of Górski et al., the phages can possibly cross the" exact="mucosa" post="and enter the systemic circulation even in healthy individuals"/>
 <result pre="the phages can possibly cross the mucosa and enter the" exact="systemic" post="circulation even in healthy individuals [51]. This transition could"/>
 <result pre="inflammation and intestinal permeability increases, so does the number of" exact="viral" post="particles in the circulation (Figure 3A,B). However, the mechanisms"/>
 <result pre="it should not be forgotten that the rapid lysis of" exact="bacterial" post="cells via the action of lytic phages may lead"/>
 <result pre="may be important. Lysogenic phages might not destroy the desired" exact="bacterial" post="strain and, thus, be so efficient in comparison with"/>
 <result pre="In addition to the immunogenicity, phages may provide bacteria via" exact="horizontal" post="gene transfer with additional genetic material (Figure 5A–E). Such"/>
 <result pre="code toxins and products facilitating, for example, adhesion to the" exact="mucosa" post="and invasion into the tissue or evasion from the"/>
 <result pre="able to convert the bacteria to produce the toxin, phage" exact="infection" post="resulted in an increase in toxin B production [58]."/>
 <result pre="infection resulted in an increase in toxin B production [58]." exact="Vibrio cholerae," post="the causative agent of cholera epidemics, has its main"/>
 <result pre="toxin B production [58]. Vibrio cholerae, the causative agent of" exact="cholera" post="epidemics, has its main two virulence factors (cholera toxin"/>
 <result pre="were characterized [59]. In addition, Salmonella typhimurium uses a specialized" exact="type III" post="secretion system to translocate effector proteins into host cells."/>
 <result pre="among Salmonella strains, and it is presumably a result of" exact="horizontal" post="gene transfer. Moreover, phages carrying antibacterial resistance genes were"/>
 <result pre="carrying antibacterial resistance genes were detected in the sputum from" exact="cystic fibrosis" post="patients [60]. Conversely, another study analyzed the abundance of"/>
 <result pre="[63]. Therefore, phage SopEPhi indirectly contributes to the development of" exact="colitis" post="in streptomycin-pretreated mice [64]. Some proteins are even able"/>
 <result pre="our group [66]. The mechanisms via which bacteriophages modulate the" exact="bacterial" post="microbiota in the gut are multifactorial. Upon incorporation into"/>
 <result pre="FMT is effective in multiple gastrointestinal diseases such as CDI," exact="irritable bowel syndrome" post="(IBS), IBD, and CRC [67,68]. For instance, in the"/>
 <result pre="is effective in multiple gastrointestinal diseases such as CDI, irritable" exact="bowel" post="syndrome (IBS), IBD, and CRC [67,68]. For instance, in"/>
 <result pre="effective in multiple gastrointestinal diseases such as CDI, irritable bowel" exact="syndrome" post="(IBS), IBD, and CRC [67,68]. For instance, in the"/>
 <result pre="IBD, and CRC [67,68]. For instance, in the case of" exact="recurrent" post="CDI, it reached the effectiveness of over 80% even"/>
 <result pre="composition of the virome after FMT found the transfer of" exact="viral" post="sequences from a healthy donor to pediatric UC patients."/>
 <result pre="very similar to the donor. Unexpectedly, the phage composition remained" exact="stable" post="for up to seven months. The composition of bacteria,"/>
 <result pre="changes in the virome correspond to the severity of the" exact="disease" post="is unavailable. Although the efficiency of FMT extends even"/>
 <result pre="immunocompromised patients. Our previous findings suggest that the effect of" exact="bacterial" post="therapy can be at least partially mediated by various"/>
 <result pre="be at least partially mediated by various parts of the" exact="bacterial" post="cell, as even non-viable bacterial vectors showed certain therapeutic"/>
 <result pre="by various parts of the bacterial cell, as even non-viable" exact="bacterial" post="vectors showed certain therapeutic effect in IBD treatment [74]."/>
 <result pre="disadvantages compared with antibiotics must be addressed. Phages are of" exact="viral" post="origin; therefore, they differ completely from antibiotics in many"/>
 <result pre="strain-specific, whereas antibiotics are active against a wide range of" exact="bacterial" post="species, often killing harmless commensals along with pathogens. This"/>
 <result pre="may, in turn, lead to other problems such as antibiotic-associated" exact="diarrhea" post="and C. difficile infection [76]. Conversely, phages do not"/>
 <result pre="to other problems such as antibiotic-associated diarrhea and C. difficile" exact="infection" post="[76]. Conversely, phages do not appear to inflict any"/>
 <result pre="upon the microbiota. These assumptions are, however, based on our" exact="incomplete" post="understanding of interactions occurring between phages and bacteria and"/>
 <result pre="depth. Although PT may be a reliable option against an" exact="infection" post="caused by a single bacterial strain, there are situations"/>
 <result pre="a reliable option against an infection caused by a single" exact="bacterial" post="strain, there are situations in which a multitude of"/>
 <result pre="be unreasonable to try to think of PT as a" exact="complete" post="substitution for antibiotics. Hence, there will always be cases"/>
 <result pre="even helpful in alleviating the symptoms of dextran sodium sulfate-induced" exact="colitis" post="in mice colonized with E. coli LF82. Strikingly, this"/>
 <result pre="ulcers in humans [89]. Additionally, in a study where whole" exact="viral" post="communities were transferred via FMT between human individuals, none"/>
 <result pre="change in the severity of inflammation during remission or relapse," exact="bacterial" post="and viral populations likely adapt to the ever-changing conditions"/>
 <result pre="the severity of inflammation during remission or relapse, bacterial and" exact="viral" post="populations likely adapt to the ever-changing conditions in the"/>
 <result pre="them) is the most suitable for the destruction of harmful" exact="bacterial" post="strains and the alleviation of gastrointestinal disease, including IBD,"/>
 <result pre="the destruction of harmful bacterial strains and the alleviation of" exact="gastrointestinal disease," post="including IBD, must be determined. In addition to the"/>
 <result pre="could not cause the excessive breakdown of bacteria in a" exact="short" post="amount of time. This could lead to a high"/>
 <result pre="benefit. However, mechanisms governing the key aspects, such as immunogenicity," exact="horizontal" post="gene transfer, or the composition of virome and phageome"/>
 <result pre="in the Human IntestineScience20053071915192010.1126/science.110481615790844 2.NgS.C.ShiH.Y.HamidiN.UnderwoodF.E.TangW.BenchimolE.I.PanaccioneR.GhoshS.WuJ.C.Y.ChanF.K.L.et al.Worldwide incidence and prevalence of" exact="inflammatory bowel disease" post="in the 21st century: A systematic review of population-based"/>
 <result pre="the Human IntestineScience20053071915192010.1126/science.110481615790844 2.NgS.C.ShiH.Y.HamidiN.UnderwoodF.E.TangW.BenchimolE.I.PanaccioneR.GhoshS.WuJ.C.Y.ChanF.K.L.et al.Worldwide incidence and prevalence of inflammatory" exact="bowel" post="disease in the 21st century: A systematic review of"/>
 <result pre="Human IntestineScience20053071915192010.1126/science.110481615790844 2.NgS.C.ShiH.Y.HamidiN.UnderwoodF.E.TangW.BenchimolE.I.PanaccioneR.GhoshS.WuJ.C.Y.ChanF.K.L.et al.Worldwide incidence and prevalence of inflammatory bowel" exact="disease" post="in the 21st century: A systematic review of population-based"/>
 <result pre="population-based studiesLancet20173902769277810.1016/S0140-6736(17)32448-029050646 3.KimJ.-W.LeeC.K.LeeJ.K.JeongS.J.OhS.J.MoonJ.R.KimH.-S.KimH.J.Long-term evolution of direct healthcare costs for inflammatory" exact="bowel" post="diseases: A population-based study (2006–2015)Scand. J. Gastroenterol.20195441942610.1080/00365521.2019.159149830905222 4.SandbornW.J.The Present"/>
 <result pre="population-based study (2006–2015)Scand. J. Gastroenterol.20195441942610.1080/00365521.2019.159149830905222 4.SandbornW.J.The Present and Future of" exact="Inflammatory" post="Bowel Disease TreatmentGastroenterol. Hepatol.201612438441 5.EckburgP.B.Diversity of the Human Intestinal"/>
 <result pre="(2006–2015)Scand. J. Gastroenterol.20195441942610.1080/00365521.2019.159149830905222 4.SandbornW.J.The Present and Future of Inflammatory Bowel" exact="Disease" post="TreatmentGastroenterol. Hepatol.201612438441 5.EckburgP.B.Diversity of the Human Intestinal Microbial FloraScience20053081635163810.1126/science.111059115831718"/>
 <result pre="of Inflammatory Bowel Disease TreatmentGastroenterol. Hepatol.201612438441 5.EckburgP.B.Diversity of the Human" exact="Intestinal" post="Microbial FloraScience20053081635163810.1126/science.111059115831718 6.QinJ.LiR.RaesJ.ArumugamM.BurgdorfK.S.ManichanhC.NielsenT.PonsN.LevenezF.YamadaT.et al.A human gut microbial gene catalogue"/>
 <result pre="Bacterial to Host Cells in HumansCell201616433734010.1016/j.cell.2016.01.01326824647 10.MaaserC.LangholzE.GordonH.BurischJ.EllulP.RamirezV.H.KarakanT.KatsanosK.H.KrustinsE.LevineA.et al.European Crohn’s and" exact="Colitis" post="Organisation Topical Review on Environmental Factors in IBDJ. Crohns"/>
 <result pre="in IBDJ. Crohns Colitis20171190592010.1093/ecco-jcc/jjx002.03828039310 11.ZengY.ChenS.FuY.WuW.ChenT.ChenJ.YangB.OuQ.Gut microbiota dysbiosis in patients with" exact="hepatitis" post="B virus-induced chronic liver disease covering chronic hepatitis, liver"/>
 <result pre="Colitis20171190592010.1093/ecco-jcc/jjx002.03828039310 11.ZengY.ChenS.FuY.WuW.ChenT.ChenJ.YangB.OuQ.Gut microbiota dysbiosis in patients with hepatitis B virus-induced" exact="chronic" post="liver disease covering chronic hepatitis, liver cirrhosis and hepatocellular"/>
 <result pre="11.ZengY.ChenS.FuY.WuW.ChenT.ChenJ.YangB.OuQ.Gut microbiota dysbiosis in patients with hepatitis B virus-induced chronic" exact="liver disease" post="covering chronic hepatitis, liver cirrhosis and hepatocellular carcinomaJ. Viral"/>
 <result pre="microbiota dysbiosis in patients with hepatitis B virus-induced chronic liver" exact="disease" post="covering chronic hepatitis, liver cirrhosis and hepatocellular carcinomaJ. Viral"/>
 <result pre="in patients with hepatitis B virus-induced chronic liver disease covering" exact="chronic hepatitis," post="liver cirrhosis and hepatocellular carcinomaJ. Viral Hepat.20202714315510.1111/jvh.1321631600845 12.HigarzaS.G.ArboleyaS.GueimondeM.Gomez-LazaroE.AriasJ.L.AriasN.Neurobehavioral dysfunction"/>
 <result pre="with hepatitis B virus-induced chronic liver disease covering chronic hepatitis," exact="liver cirrhosis" post="and hepatocellular carcinomaJ. Viral Hepat.20202714315510.1111/jvh.1321631600845 12.HigarzaS.G.ArboleyaS.GueimondeM.Gomez-LazaroE.AriasJ.L.AriasN.Neurobehavioral dysfunction in non-alcoholic"/>
 <result pre="hepatitis B virus-induced chronic liver disease covering chronic hepatitis, liver" exact="cirrhosis" post="and hepatocellular carcinomaJ. Viral Hepat.20202714315510.1111/jvh.1321631600845 12.HigarzaS.G.ArboleyaS.GueimondeM.Gomez-LazaroE.AriasJ.L.AriasN.Neurobehavioral dysfunction in non-alcoholic"/>
 <result pre="liver disease covering chronic hepatitis, liver cirrhosis and hepatocellular carcinomaJ." exact="Viral" post="Hepat.20202714315510.1111/jvh.1321631600845 12.HigarzaS.G.ArboleyaS.GueimondeM.Gomez-LazaroE.AriasJ.L.AriasN.Neurobehavioral dysfunction in non-alcoholic steatohepatitis is associated with"/>
 <result pre="ONE201914e022301910.1371/journal.pone.022301931539420 13.LiuF.LiJ.GuanY.LouY.ChenH.XuM.DengD.ChenJ.NiB.ZhaoL.et al.Dysbiosis of the Gut Microbiome is associated with" exact="Tumor" post="Biomarkers in Lung CancerInt. J. Biol. Sci.2019152381239210.7150/ijbs.3598031595156 14.MashaqiS.GozalD.Obstructive Sleep"/>
 <result pre="with Tumor Biomarkers in Lung CancerInt. J. Biol. Sci.2019152381239210.7150/ijbs.3598031595156 14.MashaqiS.GozalD.Obstructive" exact="Sleep Apnea" post="and Systemic Hypertension: Gut Dysbiosis as the Mediator?J. Clin."/>
 <result pre="in Lung CancerInt. J. Biol. Sci.2019152381239210.7150/ijbs.3598031595156 14.MashaqiS.GozalD.Obstructive Sleep Apnea and" exact="Systemic" post="Hypertension: Gut Dysbiosis as the Mediator?J. Clin. Sleep Med.2019151517152710.5664/jcsm.799031596218"/>
 <result pre="Microbiota and the Pathogenesis of Rheumatoid ArthritisJ. Immunol. Res.2017201711310.1155/2017/4835189 16.SilvermanG.J.AzzouzD.F.AlekseyenkoA.V.Systemic" exact="Lupus Erythematosus" post="and dysbiosis in the microbiome: Cause or effect or"/>
 <result pre="or both?Curr. Opin. Immunol.201961808510.1016/j.coi.2019.08.00731590039 17.YuL.C.-H.Microbiota dysbiosis and barrier dysfunction in" exact="inflammatory bowel disease" post="and colorectal cancers: Exploring a common ground hypothesisJ. Biomed."/>
 <result pre="both?Curr. Opin. Immunol.201961808510.1016/j.coi.2019.08.00731590039 17.YuL.C.-H.Microbiota dysbiosis and barrier dysfunction in inflammatory" exact="bowel" post="disease and colorectal cancers: Exploring a common ground hypothesisJ."/>
 <result pre="Opin. Immunol.201961808510.1016/j.coi.2019.08.00731590039 17.YuL.C.-H.Microbiota dysbiosis and barrier dysfunction in inflammatory bowel" exact="disease" post="and colorectal cancers: Exploring a common ground hypothesisJ. Biomed."/>
 <result pre="19.MaY.YouX.MaiG.TokuyasuT.LiuC.A human gut phage catalog correlates the gut phageome with" exact="type 2" post="diabetesMicrobiome201862410.1186/s40168-018-0410-y29391057 20.TetzG.BrownS.M.HaoY.TetzV.Parkinson’s disease and bacteriophages as its overlooked contributorsSci."/>
 <result pre="catalog correlates the gut phageome with type 2 diabetesMicrobiome201862410.1186/s40168-018-0410-y29391057 20.TetzG.BrownS.M.HaoY.TetzV.Parkinson’s" exact="disease" post="and bacteriophages as its overlooked contributorsSci. Rep.201881081210.1038/s41598-018-29173-430018338 21.BreitbartM.HewsonI.FeltsB.MahaffyJ.M.NultonJ.SalamonP.RohwerF.Metagenomic Analyses"/>
 <result pre="as its overlooked contributorsSci. Rep.201881081210.1038/s41598-018-29173-430018338 21.BreitbartM.HewsonI.FeltsB.MahaffyJ.M.NultonJ.SalamonP.RohwerF.Metagenomic Analyses of an Uncultured" exact="Viral" post="Community from Human FecesJ. Bacteriol.20031856220622310.1128/JB.185.20.6220-6223.200314526037 22.ReyesA.HaynesM.HansonN.AnglyF.E.HeathA.C.RohwerF.GordonJ.I.Viruses in the faecal"/>
 <result pre="microbiota of monozygotic twins and their mothersNature201046633433810.1038/nature0919920631792 23.Prez-BrocalV.Garca-LpezR.Vzquez-CastellanosJ.F.NosP.BeltrnB.LatorreA.MoyaA.Study of the" exact="Viral" post="and Microbial Communities Associated With Crohn’s Disease: A Metagenomic"/>
 <result pre="Disease: A Metagenomic ApproachClin. Transl. Gastroenterol.20134e3610.1038/ctg.2013.923760301 24.Prez-BrocalV.Garcia-LopezR.NosP.BeltranB.MoretI.MoyaA.Metagenomic Analysis of Crohn’s" exact="Disease" post="Patients Identifies Changes in the Virome and Microbiome Related"/>
 <result pre="Patients Identifies Changes in the Virome and Microbiome Related to" exact="Disease" post="Status and Therapy, and Detects Potential Interactions and BiomarkersInflamm."/>
 <result pre="Detects Potential Interactions and BiomarkersInflamm. Bowel Dis.2015212515253210.1097/MIB.000000000000054926313691 25.LepageP.ColombetJ.MarteauP.Sime-NgandoT.DoreJ.LeclercM.Dysbiosis in inflammatory" exact="bowel" post="disease: A role for bacteriophages?Gut20085742442510.1136/gut.2007.13466818268057 26.SwidsinskiA.LadhoffA.PernthalerA.SwidsinskiS.Loening–BauckeV.OrtnerM.WeberJ.HoffmannU.SchreiberS.DietelM.et al.Mucosal flora in"/>
 <result pre="disease: A role for bacteriophages?Gut20085742442510.1136/gut.2007.13466818268057 26.SwidsinskiA.LadhoffA.PernthalerA.SwidsinskiS.Loening–BauckeV.OrtnerM.WeberJ.HoffmannU.SchreiberS.DietelM.et al.Mucosal flora in inflammatory" exact="bowel" post="diseaseGastroenterology2002122445410.1053/gast.2002.3029411781279 27.SwidsinskiA.WeberJ.Loening-BauckeV.HaleL.P.LochsH.Spatial Organization and Composition of the Mucosal Flora"/>
 <result pre="in inflammatory bowel diseaseGastroenterology2002122445410.1053/gast.2002.3029411781279 27.SwidsinskiA.WeberJ.Loening-BauckeV.HaleL.P.LochsH.Spatial Organization and Composition of the" exact="Mucosal" post="Flora in Patients with Inflammatory Bowel DiseaseJ. Clin. Microbiol.2005433380338910.1128/JCM.43.7.3380-3389.200516000463"/>
 <result pre="Organization and Composition of the Mucosal Flora in Patients with" exact="Inflammatory" post="Bowel DiseaseJ. Clin. Microbiol.2005433380338910.1128/JCM.43.7.3380-3389.200516000463 28.WagnerJ.MaksimovicJ.FarriesG.SimW.H.BishopR.F.CameronD.J.Catto-SmithA.G.KirkwoodC.D.Bacteriophages in Gut Samples From"/>
 <result pre="Inflammatory Bowel DiseaseJ. Clin. Microbiol.2005433380338910.1128/JCM.43.7.3380-3389.200516000463 28.WagnerJ.MaksimovicJ.FarriesG.SimW.H.BishopR.F.CameronD.J.Catto-SmithA.G.KirkwoodC.D.Bacteriophages in Gut Samples From" exact="Pediatric" post="Crohn’s Disease PatientsInflamm. Bowel Dis.2013191598160810.1097/MIB.0b013e318292477c23749273 29.NormanJ.M.HandleyS.A.BaldridgeM.T.DroitL.LiuC.Y.KellerB.C.KambalA.MonacoC.L.ZhaoG.FleshnerP.et al.Disease-Specific Alterations in"/>
 <result pre="DiseaseJ. Clin. Microbiol.2005433380338910.1128/JCM.43.7.3380-3389.200516000463 28.WagnerJ.MaksimovicJ.FarriesG.SimW.H.BishopR.F.CameronD.J.Catto-SmithA.G.KirkwoodC.D.Bacteriophages in Gut Samples From Pediatric Crohn’s" exact="Disease" post="PatientsInflamm. Bowel Dis.2013191598160810.1097/MIB.0b013e318292477c23749273 29.NormanJ.M.HandleyS.A.BaldridgeM.T.DroitL.LiuC.Y.KellerB.C.KambalA.MonacoC.L.ZhaoG.FleshnerP.et al.Disease-Specific Alterations in the Enteric"/>
 <result pre="Bowel Dis.2013191598160810.1097/MIB.0b013e318292477c23749273 29.NormanJ.M.HandleyS.A.BaldridgeM.T.DroitL.LiuC.Y.KellerB.C.KambalA.MonacoC.L.ZhaoG.FleshnerP.et al.Disease-Specific Alterations in the Enteric Virome in" exact="Inflammatory" post="Bowel DiseaseCell201516044746010.1016/j.cell.2015.01.00225619688 30.DuerkopB.A.KleinerM.Paez-EspinoD.ZhuW.BushnellB.HassellB.WinterS.E.KyrpidesN.C.HooperL.V.Murine colitis reveals a disease-associated bacteriophage communityNat."/>
 <result pre="Alterations in the Enteric Virome in Inflammatory Bowel DiseaseCell201516044746010.1016/j.cell.2015.01.00225619688 30.DuerkopB.A.KleinerM.Paez-EspinoD.ZhuW.BushnellB.HassellB.WinterS.E.KyrpidesN.C.HooperL.V.Murine" exact="colitis" post="reveals a disease-associated bacteriophage communityNat. Microbiol.201831023103110.1038/s41564-018-0210-y30038310 31.FernandesM.A.VerstraeteS.G.PhanT.G.DengX.StekolE.LaMereB.LynchS.V.HeymanM.B.DelwartE.Enteric Virome and"/>
 <result pre="communityNat. Microbiol.201831023103110.1038/s41564-018-0210-y30038310 31.FernandesM.A.VerstraeteS.G.PhanT.G.DengX.StekolE.LaMereB.LynchS.V.HeymanM.B.DelwartE.Enteric Virome and Bacterial Microbiota in Children With" exact="Ulcerative Colitis" post="and Crohn DiseaseJ. Pediatr. Gastroenterol. Nutr.201968303610.1097/MPG.000000000000214030169455 32.ZuoT.LuX.-J.ZhangY.CheungC.P.LamS.ZhangF.TangW.ChingJ.Y.L.ZhaoR.ChanP.K.S.et al.Gut mucosal"/>
 <result pre="Microbiol.201831023103110.1038/s41564-018-0210-y30038310 31.FernandesM.A.VerstraeteS.G.PhanT.G.DengX.StekolE.LaMereB.LynchS.V.HeymanM.B.DelwartE.Enteric Virome and Bacterial Microbiota in Children With Ulcerative" exact="Colitis" post="and Crohn DiseaseJ. Pediatr. Gastroenterol. Nutr.201968303610.1097/MPG.000000000000214030169455 32.ZuoT.LuX.-J.ZhangY.CheungC.P.LamS.ZhangF.TangW.ChingJ.Y.L.ZhaoR.ChanP.K.S.et al.Gut mucosal"/>
 <result pre="Virome and Bacterial Microbiota in Children With Ulcerative Colitis and" exact="Crohn" post="DiseaseJ. Pediatr. Gastroenterol. Nutr.201968303610.1097/MPG.000000000000214030169455 32.ZuoT.LuX.-J.ZhangY.CheungC.P.LamS.ZhangF.TangW.ChingJ.Y.L.ZhaoR.ChanP.K.S.et al.Gut mucosal virome alterations"/>
 <result pre="of Stool Virome in Children Newly Diagnosed With Moderate to" exact="Severe" post="Ulcerative ColitisInflamm. Bowel Dis.2019251656166210.1093/ibd/izz09931112614 34.ZuoT.WongS.H.LamK.LuiR.CheungK.TangW.ChingJ.Y.L.ChanP.K.S.ChanM.C.W.WuJ.C.Y.et al.Bacteriophage transfer during faecal"/>
 <result pre="34.ZuoT.WongS.H.LamK.LuiR.CheungK.TangW.ChingJ.Y.L.ChanP.K.S.ChanM.C.W.WuJ.C.Y.et al.Bacteriophage transfer during faecal microbiota transplantation in Clostridium difficile" exact="infection" post="is associated with treatment outcomeGut20176763464328539351 35.HanniganG.D.DuhaimeM.B.RuffinM.T.KoumpourasC.C.SchlossP.D.Diagnostic Potential and Interactive"/>
 <result pre="with treatment outcomeGut20176763464328539351 35.HanniganG.D.DuhaimeM.B.RuffinM.T.KoumpourasC.C.SchlossP.D.Diagnostic Potential and Interactive Dynamics of the" exact="Colorectal Cancer" post="ViromemBio2018911310.1128/mBio.02248-18 36.NakatsuG.ZhouH.WuW.K.K.WongS.H.CokerO.O.DaiZ.LiX.SzetoC.-H.SugimuraN.LamT.Y.-T.et al.Alterations in Enteric Virome Are Associated With"/>
 <result pre="treatment outcomeGut20176763464328539351 35.HanniganG.D.DuhaimeM.B.RuffinM.T.KoumpourasC.C.SchlossP.D.Diagnostic Potential and Interactive Dynamics of the Colorectal" exact="Cancer" post="ViromemBio2018911310.1128/mBio.02248-18 36.NakatsuG.ZhouH.WuW.K.K.WongS.H.CokerO.O.DaiZ.LiX.SzetoC.-H.SugimuraN.LamT.Y.-T.et al.Alterations in Enteric Virome Are Associated With"/>
 <result pre="Cancer ViromemBio2018911310.1128/mBio.02248-18 36.NakatsuG.ZhouH.WuW.K.K.WongS.H.CokerO.O.DaiZ.LiX.SzetoC.-H.SugimuraN.LamT.Y.-T.et al.Alterations in Enteric Virome Are Associated With" exact="Colorectal Cancer" post="and Survival OutcomesGastroenterology2018155529.e5541.e510.1053/j.gastro.2018.04.01829689266 37.WangW.JovelJ.HalloranB.WineE.PattersonJ.FordG.O’KeefeS.MengB.SongD.ZhangY.et al.Metagenomic analysis of microbiome in"/>
 <result pre="ViromemBio2018911310.1128/mBio.02248-18 36.NakatsuG.ZhouH.WuW.K.K.WongS.H.CokerO.O.DaiZ.LiX.SzetoC.-H.SugimuraN.LamT.Y.-T.et al.Alterations in Enteric Virome Are Associated With Colorectal" exact="Cancer" post="and Survival OutcomesGastroenterology2018155529.e5541.e510.1053/j.gastro.2018.04.01829689266 37.WangW.JovelJ.HalloranB.WineE.PattersonJ.FordG.O’KeefeS.MengB.SongD.ZhangY.et al.Metagenomic analysis of microbiome in"/>
 <result pre="al.Metagenomic analysis of microbiome in colon tissue from subjects with" exact="inflammatory bowel diseases" post="reveals interplay of viruses and bacteriaInflamm. Bowel Dis.2015211419142710.1097/MIB.000000000000034425939040 38.UngaroF.MassiminoL.FurfaroF.RimoldiV.Peyrin-BirouletL.D’AlessioS.DaneseS.Metagenomic"/>
 <result pre="analysis of microbiome in colon tissue from subjects with inflammatory" exact="bowel" post="diseases reveals interplay of viruses and bacteriaInflamm. Bowel Dis.2015211419142710.1097/MIB.000000000000034425939040"/>
 <result pre="of viruses and bacteriaInflamm. Bowel Dis.2015211419142710.1097/MIB.000000000000034425939040 38.UngaroF.MassiminoL.FurfaroF.RimoldiV.Peyrin-BirouletL.D’AlessioS.DaneseS.Metagenomic analysis of intestinal" exact="mucosa" post="revealed a specific eukaryotic gut virome signature in early-diagnosed"/>
 <result pre="revealed a specific eukaryotic gut virome signature in early-diagnosed inflammatory" exact="bowel" post="diseaseGut Microbes20191014915810.1080/19490976.2018.151166430252582 39.HamptonH.G.WatsonB.N.J.FineranP.C.The arms race between bacteria and their"/>
 <result pre="and their phage foesNature202057732733610.1038/s41586-019-1894-831942051 40.ClooneyA.G.SuttonT.D.S.ShkoporovA.N.HolohanR.K.DalyK.M.O’ReganO.RyanF.J.DraperL.A.PlevyS.E.RossR.P.et al.Whole-Virome Analysis Sheds Light on" exact="Viral" post="Dark Matter in Inflammatory Bowel DiseaseCell Host Microbe201926764.e5778.e510.1016/j.chom.2019.10.00931757768 41.ShkoporovA.N.ClooneyA.G.SuttonT.D.S.RyanF.J.DalyK.M.NolanJ.A.McDonnellS.A.KhokhlovaE.V.DraperL.A.FordeA.et"/>
 <result pre="40.ClooneyA.G.SuttonT.D.S.ShkoporovA.N.HolohanR.K.DalyK.M.O’ReganO.RyanF.J.DraperL.A.PlevyS.E.RossR.P.et al.Whole-Virome Analysis Sheds Light on Viral Dark Matter in" exact="Inflammatory" post="Bowel DiseaseCell Host Microbe201926764.e5778.e510.1016/j.chom.2019.10.00931757768 41.ShkoporovA.N.ClooneyA.G.SuttonT.D.S.RyanF.J.DalyK.M.NolanJ.A.McDonnellS.A.KhokhlovaE.V.DraperL.A.FordeA.et al.The Human Gut Virome"/>
 <result pre="Individual SpecificCell Host Microbe201926527.e5541.e510.1016/j.chom.2019.09.00931600503 42.KnowlesB.SilveiraC.B.BaileyB.A.BarottK.CantuV.A.Cobin-GemesA.G.CoutinhoF.H.DinsdaleE.A.FeltsB.FurbyK.A.et al.Lytic to temperate switching of" exact="viral" post="communitiesNature201653146647010.1038/nature1719326982729 43.SinhaA.MauriceC.F.Bacteriophages: Uncharacterized and Dynamic Regulators of the Immune"/>
 <result pre="therapyFront. Microbiol.2016711410.3389/fmicb.2016.0168126834723 49.GogokhiaL.BuhrkeK.BellR.HoffmanB.BrownD.G.Hanke-GogokhiaC.AjamiN.J.WongM.C.GhazaryanA.ValentineJ.F.et al.Expansion of Bacteriophages Is Linked to Aggravated" exact="Intestinal" post="Inflammation and ColitisCell Host Microbe201925285.e8299.e810.1016/j.chom.2019.01.00830763538 50.MiedzybrodzkiR.Switala-JelenK.FortunaW.Weber-DabrowskaB.PrzerwaA.Lusiak-SzelachowskaM.DabrowskaK.KurzepaA.BoratynskiJ.SyperD.et al.Bacteriophage preparation inhibition"/>
 <result pre="Proc.20063833133310.1016/j.transproceed.2005.12.07316504739 52.ZhangL.HouX.SunL.HeT.WeiR.PangM.WangR.Corrigendum: Staphylococcus aureus Bacteriophage Suppresses LPS-Induced Inflammation in MAC-T" exact="Bovine" post="Mammary Epithelial CellsFront. Microbiol.20189338910.3389/fmicb.2018.0251130450085 53.GórskiA.BollykyP.L.PrzybylskiM.BorysowskiJ.MiędzybrodzkiR.Jończyk-MatysiakE.Weber-DąbrowskaB.Perspectives of Phage Therapy in"/>
 <result pre="phages: Highly diverse entitiesMicrobiology201516111210.1099/mic.0.00000325288645 57.SakaguchiY.HayashiT.KurokawaK.NakayamaK.OshimaK.FujinagaY.OhnishiM.OhtsuboE.HattoriM.OgumaK.The genome sequence of Clostridium botulinum" exact="type C" post="neurotoxin-converting phage and the molecular mechanisms of unstable lysogenyProc."/>
 <result pre="of unstable lysogenyProc. Natl. Acad. Sci. USA2005102174721747710.1073/pnas.050550310216287978 58.GohS.Effect of phage" exact="infection" post="on toxin production by Clostridium difficileJ. Med. Microbiol.20055412913510.1099/jmm.0.45821-015673505 59.FaruqueS.M.MekalanosJ.J.Phage-bacterial"/>
 <result pre="choleraeVirulence2012355656510.4161/viru.2235123076327 60.Brown-JaqueM.Rodriguez OyarzunL.Cornejo-SánchezT.Martín-GómezM.T.GartnerS.de GraciaJ.RoviraS.AlvarezA.JofreJ.González-LópezJ.J.et al.Detection of Bacteriophage Particles Containing Antibiotic" exact="Resistance" post="Genes in the Sputum of Cystic Fibrosis PatientsFront. Microbiol.2018911010.3389/fmicb.2018.0085629403456"/>
 <result pre="Bacteriophage Particles Containing Antibiotic Resistance Genes in the Sputum of" exact="Cystic" post="Fibrosis PatientsFront. Microbiol.2018911010.3389/fmicb.2018.0085629403456 61.EnaultF.BrietA.BouteilleL.RouxS.SullivanM.B.PetitM.-A.Phages rarely encode antibiotic resistance genes:"/>
 <result pre="virome analysesISME J.20171123724710.1038/ismej.2016.9027326545 62.MiroldS.RabschW.RohdeM.StenderS.TschpeH.RssmannH.IgweE.HardtW.D.Isolation of a temperate bacteriophage encoding the" exact="type III" post="effector protein SopE from an epidemic Salmonella typhimurium strainProc."/>
 <result pre="SopE, and SopE2 in Salmonella enterica Subspecies 1 Serovar Typhimurium" exact="Colitis" post="in Streptomycin-Pretreated MiceInfect. Immun.20047279580910.1128/IAI.72.2.795-809.200414742523 65.PostmaB.PoppelierM.J.van GalenJ.C.ProssnitzE.R.van StrijpJ.A.G.de HaasC.J.C.van KesselK.P.M.Chemotaxis"/>
 <result pre="in Streptomycin-Pretreated MiceInfect. Immun.20047279580910.1128/IAI.72.2.795-809.200414742523 65.PostmaB.PoppelierM.J.van GalenJ.C.ProssnitzE.R.van StrijpJ.A.G.de HaasC.J.C.van KesselK.P.M.Chemotaxis Inhibitory" exact="Protein" post="of Staphylococcus aureus Binds Specifically to the C5a and"/>
 <result pre="therapeutic interactions between bacteriophages, microbes and the host in inflammatory" exact="bowel" post="diseaseWorld J. Gastroenterol.201521113211133010.3748/wjg.v21.i40.1132126525290 67.BorodyT.J.EslickG.D.ClancyR.L.Fecal microbiota transplantation as a new"/>
 <result pre="67.BorodyT.J.EslickG.D.ClancyR.L.Fecal microbiota transplantation as a new therapy: From Clostridioides difficile" exact="infection" post="to inflammatory bowel disease, irritable bowel syndrome, and colon"/>
 <result pre="transplantation as a new therapy: From Clostridioides difficile infection to" exact="inflammatory bowel disease," post="irritable bowel syndrome, and colon cancerCurr. Opin. Pharmacol.201949435110.1016/j.coph.2019.04.01731173991 68.NowakA.HedenstiernaM.UrsingJ.LidmanC.NowakP.Efficacy"/>
 <result pre="as a new therapy: From Clostridioides difficile infection to inflammatory" exact="bowel" post="disease, irritable bowel syndrome, and colon cancerCurr. Opin. Pharmacol.201949435110.1016/j.coph.2019.04.01731173991"/>
 <result pre="new therapy: From Clostridioides difficile infection to inflammatory bowel disease," exact="irritable bowel syndrome," post="and colon cancerCurr. Opin. Pharmacol.201949435110.1016/j.coph.2019.04.01731173991 68.NowakA.HedenstiernaM.UrsingJ.LidmanC.NowakP.Efficacy of Routine Fecal"/>
 <result pre="therapy: From Clostridioides difficile infection to inflammatory bowel disease, irritable" exact="bowel" post="syndrome, and colon cancerCurr. Opin. Pharmacol.201949435110.1016/j.coph.2019.04.01731173991 68.NowakA.HedenstiernaM.UrsingJ.LidmanC.NowakP.Efficacy of Routine"/>
 <result pre="Pharmacol.201949435110.1016/j.coph.2019.04.01731173991 68.NowakA.HedenstiernaM.UrsingJ.LidmanC.NowakP.Efficacy of Routine Fecal Microbiota Transplantation for Treatment of" exact="Recurrent" post="Clostridium difficile Infection: A Retrospective Cohort StudyInt. J. Microbiol.201920191710.1155/2019/7395127"/>
 <result pre="Microbiol.201920191710.1155/2019/7395127 69.Van NoodE.VriezeA.NieuwdorpM.FuentesS.ZoetendalE.G.de VosW.M.VisserC.E.KuijperE.J.BartelsmanJ.F.W.M.TijssenJ.G.P.et al.Duodenal Infusion of Donor Feces for" exact="Recurrent" post="Clostridium difficileN. Engl. J. Med.201336840741510.1056/NEJMoa120503723323867 70.ChehoudC.DrygaA.HwangY.Nagy-SzakalD.HollisterE.B.LunaR.A.VersalovicJ.KellermayerR.BushmanF.D.Transfer of Viral Communities"/>
 <result pre="Feces for Recurrent Clostridium difficileN. Engl. J. Med.201336840741510.1056/NEJMoa120503723323867 70.ChehoudC.DrygaA.HwangY.Nagy-SzakalD.HollisterE.B.LunaR.A.VersalovicJ.KellermayerR.BushmanF.D.Transfer of" exact="Viral" post="Communities between Human Individuals during Fecal Microbiota TransplantationmBio201671810.1128/mBio.00322-16 71.BroeckerF.RussoG.KlumppJ.MoellingK.Stable"/>
 <result pre="live and dead Salmonella-based vector strain on the course of" exact="colitis" post="in miceLett. Appl. Microbiol.20166334034610.1111/lam.1263227501439 75.LiptakR.GromovaB.MaronekM.GardlikR.Reverse phenotype transfer via fecal"/>
 <result pre="Microbiol.20166334034610.1111/lam.1263227501439 75.LiptakR.GromovaB.MaronekM.GardlikR.Reverse phenotype transfer via fecal microbial transplantation in inflammatory" exact="bowel" post="diseaseMed. Hypotheses2019122414410.1016/j.mehy.2018.10.01730593419 76.ReaK.DinanT.G.CryanJ.F.The microbiome: A key regulator of stress"/>
 <result pre="natural and genetically-modified phagesWorld J. Microbiol. Biotechnol.2016326710.1007/s11274-016-2009-426931607 81.ChassaingB.KorenO.CarvalhoF.A.LeyR.E.GewirtzA.T.AIEC pathobiont instigates" exact="chronic" post="colitis in susceptible hosts by altering microbiota compositionGut2014631069108010.1136/gutjnl-2013-30490923896971 82.BretinA.LucasC.LarabiA.DalmassoG.BillardE.BarnichN.BonnetR.NguyenH.T.T.AIEC"/>
 <result pre="and genetically-modified phagesWorld J. Microbiol. Biotechnol.2016326710.1007/s11274-016-2009-426931607 81.ChassaingB.KorenO.CarvalhoF.A.LeyR.E.GewirtzA.T.AIEC pathobiont instigates chronic" exact="colitis" post="in susceptible hosts by altering microbiota compositionGut2014631069108010.1136/gutjnl-2013-30490923896971 82.BretinA.LucasC.LarabiA.DalmassoG.BillardE.BarnichN.BonnetR.NguyenH.T.T.AIEC infection"/>
 <result pre="chronic colitis in susceptible hosts by altering microbiota compositionGut2014631069108010.1136/gutjnl-2013-30490923896971 82.BretinA.LucasC.LarabiA.DalmassoG.BillardE.BarnichN.BonnetR.NguyenH.T.T.AIEC" exact="infection" post="triggers modification of gut microbiota composition in genetically predisposed"/>
 <result pre="contributing to intestinal inflammationSci. Rep.201881230110.1038/s41598-018-30055-y30120269 83.PalmelaC.ChevarinC.XuZ.TorresJ.SevrinG.HirtenR.BarnichN.NgS.C.ColombelJ.F.Adherent-invasive Escherichia coli in inflammatory" exact="bowel" post="diseaseGut20186757458710.1136/gutjnl-2017-31490329141957 84.GaltierM.A.Bacteriophages targeting adherent invasive Escherichia coli strains as"/>
 <result pre="bacteriophage for phage therapyAdv. Colloid Interface Sci.201724910013310.1016/j.cis.2017.05.01428688779 87.McCallinS.SarkerS.A.SultanaS.OechslinF.BrssowH.Metagenome analysis of" exact="Russian" post="and Georgian Pyophage cocktails and a placebo-controlled safety trial"/>
 <result pre="aureus carriersEnviron. Microbiol.2018203278329310.1111/1462-2920.1431030051571 88.OoiM.L.DrillingA.J.MoralesS.FongS.MoraitisS.MacIas-ValleL.VreugdeS.PsaltisA.J.WormaldP.J.Safety and tolerability of bacteriophage therapy for" exact="chronic" post="rhinosinusitis due to staphylococcus aureusJAMA Otolaryngol. Head Neck Surg.201914572372910.1001/jamaoto.2019.1191"/>
 <result pre="carriersEnviron. Microbiol.2018203278329310.1111/1462-2920.1431030051571 88.OoiM.L.DrillingA.J.MoralesS.FongS.MoraitisS.MacIas-ValleL.VreugdeS.PsaltisA.J.WormaldP.J.Safety and tolerability of bacteriophage therapy for chronic" exact="rhinosinusitis" post="due to staphylococcus aureusJAMA Otolaryngol. Head Neck Surg.201914572372910.1001/jamaoto.2019.1191 89.RhoadsD.D.WolcottR.D.KuskowskiM.A.WolcottB.M.WardL.S.SulakvelidzeA.Bacteriophage"/>
 <result pre="lead to antibody formation (B) and the degradation of the" exact="viral" post="particle (C). Figure 3 Presence of phages in circulation."/>
 <result pre="(C). Figure 5 Horizontal gene transfer. In the process of" exact="viral infection" post="(A,B), bacteria may be equipped with additional genes (C),"/>
 <result pre="Figure 5 Horizontal gene transfer. In the process of viral" exact="infection" post="(A,B), bacteria may be equipped with additional genes (C),"/>
</results>
